hexapeptide
GHRP-6
Answer
GHRP-6 is not authorised on any of the 10 registers read, and 1 of them holds no reading for it. No trial states a phase. It has 40 registered trials, 8 of them running.
RegulatorTrial register10 regulators' registers, read 2026-08-31 to 2026-10-03 · ClinicalTrials.gov, read 2026-10-03
Not medical, legal or regulatory advice.
40 trials by status
Trial registerClinicalTrials.gov · read 2026-10-03 · 2 trials have posted results
Trials first submitted per year
Trial registerClinicalTrials.gov first-submitted date, last 10 years · read 2026-10-03. 2026 is not complete. 17 trials carry no first-submitted date (EU CTIS publishes none, or the year is outside this range).
Status by jurisdiction
World map| Where | Status | Register | Read |
|---|---|---|---|
| United States | Not on the register | FDA, openfda | 2026-10-03 |
| European Union | Not on the register | EMA, ema | 2026-08-31 |
| United Kingdom | Not on the register | MHRA, uk-mhra | 2026-09-03 |
| Canada | Not on the register | Health Canada, ca-dpd | 2026-09-03 |
| Australia | Status unknown | TGA, au-artg | not read |
| Switzerland | Not on the register | Swissmedic, ch-swissmedic | 2026-09-03 |
| Brazil | Not on the register | ANVISA, br-anvisa | 2026-09-03 |
| Serbia | Not on the register | ALIMS, rs-alims | 2026-09-03 |
| Singapore | Not on the register | HSA, sg-hsa | 2026-09-03 |
| Turkey | Not on the register | TITCK, tr-titck | 2026-09-03 |
An EU decision applies in the 30 territories the EU register covers: its member states, and Iceland, Liechtenstein and Norway. A dashed tile has no register read for this peptide.
CHANGE ALERTS
Get an email when this changes
One email when the status of GHRP-6 changes on the register. You confirm your address first.
REGISTERED TRIALS
Newest 10 of 40 trials
| NCT07171723 | Studying the Influence of LEAP2 on Integrated Endocrine Control of Eating During Semaglutide Treatment completed · register updated 2026-09-29 |
|---|---|
| NCT05870579 | [177Lu]Lu-NeoB in Combination With Ribociclib and Fulvestrant in Participants With ER+, HER2- and GRPR+ Advanced Breast Cancer running, but no longer enrolling · register updated 2026-09-11 |
| NCT05607004 | (Z)-Endoxifen for the Treatment of Premenopausal Women With ER+/HER2- Breast Cancer running, but no longer enrolling · register updated 2026-07-08 |
| NCT05617885 | Neo-DAB: Darolutamide and Abemaciclib in Prostate Cancer completed · register updated 2026-06-16 |
| NCT07636239 | Eating Behavior, Nutritional Status and Appetite Hormones After Bariatric Surgery not yet recruiting participants · register updated 2026-06-09 |
| NCT06451120 | Platelet Rich Plasma Injections In Young And Old Human Subjects currently recruiting participants · register updated 2026-03-19 |
| NCT06348134 | Assessing the Efficacy and Safety of Anti-HER2 Therapy in Nigerian Women With HER2+ Breast Cancer Before and After Surgery currently recruiting participants · register updated 2026-02-17 |
| NCT01746849 | Palifermin With Leuprolide Acetate for the Promotion of Immune Recovery Following Total Body Irradiation Based T-Cell Depleted All running, but no longer enrolling · register updated 2026-01-07 |
| NCT04964466 | Release Kinetics in PRF Versus GEM21S With and Without Bone Substitutes: An In Vitro Analysis running, but no longer enrolling · register updated 2025-12-02 |
| NCT07104461 | Advanced Protein-based Program for Effective Treatment of Appetite Regulation and Obesity completed · register updated 2025-08-21 |
WEEKLY
Register Watch, weekly
New trials, approvals and enforcement actions. One email a week.